Disulfiram Overcomes Cisplatin Resistance in Human Embryonal Carcinoma Cells
Published 2019 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Disulfiram Overcomes Cisplatin Resistance in Human Embryonal Carcinoma Cells
Authors
Keywords
-
Journal
Cancers
Volume 11, Issue 9, Pages 1224
Publisher
MDPI AG
Online
2019-08-23
DOI
10.3390/cancers11091224
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Disulfiram and BKM120 in Combination with Chemotherapy Impede Tumor Progression and Delay Tumor Recurrence in Tumor Initiating Cell-Rich TNBC
- (2019) Ling Wu et al. Scientific Reports
- Systematic chemical screening identifies disulfiram as a repositionable drug that enhances sensitivity to cisplatin in bladder cancer: A summary of preclinical studies
- (2019) Y. Kita et al. EUROPEAN UROLOGY SUPPLEMENTS
- Disulfiram modulates ROS accumulation and overcomes synergistically cisplatin resistance in breast cancer cell lines
- (2019) Zhi Yang et al. BIOMEDICINE & PHARMACOTHERAPY
- Repurposing Disulfiram as an Anti-Cancer Agent: Updated Review on Literature and Patents
- (2019) Elmira Ekincia et al. Recent Patents on Anti-Cancer Drug Discovery
- Disulfiram (Antabuse) Activates ROS-Dependent ER Stress and Apoptosis in Oral Cavity Squamous Cell Carcinoma
- (2019) Priyanka Shah O’Brien et al. Journal of Clinical Medicine
- Disulfiram’s anti-cancer activity reflects targeting NPL4, not inhibition of aldehyde dehydrogenase
- (2019) Zdenek Skrott et al. ONCOGENE
- ALDH1A inhibition sensitizes colon cancer cells to chemotherapy
- (2018) Z. Kozovska et al. BMC CANCER
- Molecular mechanisms of resistance in testicular germ cell tumors – Clinical implications
- (2018) Katarina Kalavska et al. CURRENT CANCER DRUG TARGETS
- ALDH1A3 upregulation and spontaneous metastasis formation is associated with acquired chemoresistance in colorectal cancer cells
- (2018) Erika Durinikova et al. BMC CANCER
- Identification of cancer-type specific expression patterns for active aldehyde dehydrogenase (ALDH) isoforms in ALDEFLUOR assay
- (2018) Lei Zhou et al. CELL BIOLOGY AND TOXICOLOGY
- Anti-cancer effects of disulfiram in head and neck squamous cell carcinoma via autophagic cell death
- (2018) Young Min Park et al. PLoS One
- Alcohol-abuse drug disulfiram targets cancer via p97 segregase adaptor NPL4
- (2017) Zdenek Skrott et al. NATURE
- Efficacy of targeted drugs in germ cell cancer cell lines with differential cisplatin sensitivity
- (2017) Judith Schaffrath et al. PLoS One
- Disulfiram/copper selectively eradicates AML leukemia stem cells in vitro and in vivo by simultaneous induction of ROS-JNK and inhibition of NF-κB and Nrf2
- (2017) Bing Xu et al. Cell Death & Disease
- Targeting the cancer stem cell marker, aldehyde dehydrogenase 1, to circumvent cisplatin resistance in NSCLC
- (2017) Lauren MacDonagh et al. Oncotarget
- High-Content Monitoring of Drug Effects in a 3D Spheroid Model
- (2017) Frédérique Mittler et al. Frontiers in Oncology
- ALDH1A3, the Major Aldehyde Dehydrogenase Isoform in Human Cholangiocarcinoma Cells, Affects Prognosis and Gemcitabine Resistance in Cholangiocarcinoma Patients
- (2016) Ming-Huang Chen et al. CLINICAL CANCER RESEARCH
- Mechanisms of cisplatin resistance and targeting of cancer stem cells: Adding glycosylation to the equation
- (2016) José Alexandre Ferreira et al. DRUG RESISTANCE UPDATES
- The 2016 WHO Classification of Tumours of the Urinary System and Male Genital Organs—Part A: Renal, Penile, and Testicular Tumours
- (2016) Holger Moch et al. EUROPEAN UROLOGY
- The World Health Organization 2016 classification of testicular germ cell tumours: a review and update from the International Society of Urological Pathology Testis Consultation Panel
- (2016) Sean R Williamson et al. HISTOPATHOLOGY
- Cancer stem cells and chemoresistance: The smartest survives the raid
- (2016) Jihe Zhao PHARMACOLOGY & THERAPEUTICS
- Targeting ALDH1A1 by disulfiram/copper complex inhibits non-small cell lung cancer recurrence driven by ALDH-positive cancer stem cells
- (2016) Xinwei Liu et al. Oncotarget
- Refractory testicular germ cell tumors are highly sensitive to the second generation DNA methylation inhibitor guadecitabine
- (2016) Costantine Albany et al. Oncotarget
- Copper improves the anti-angiogenic activity of disulfiram through the EGFR/Src/VEGF pathway in gliomas
- (2015) Yi Li et al. CANCER LETTERS
- Disulfiram (DSF) acts as a copper ionophore to induce copper-dependent oxidative stress and mediate anti-tumor efficacy in inflammatory breast cancer
- (2015) Jennifer L. Allensworth et al. Molecular Oncology
- A Phase IIb Trial Assessing the Addition of Disulfiram to Chemotherapy for the Treatment of Metastatic Non-Small Cell Lung Cancer
- (2015) H. Nechushtan et al. ONCOLOGIST
- Comparison of 2D- and 3D-culture models as drug-testing platforms in breast cancer
- (2015) YOSHINORI IMAMURA et al. ONCOLOGY REPORTS
- Cisplatin-resistant cells in malignant pleural mesothelioma cell lines show ALDHhighCD44+ phenotype and sphere-forming capacity
- (2014) Lourdes Cortes-Dericks et al. BMC CANCER
- Cisplatin in cancer therapy: Molecular mechanisms of action
- (2014) Shaloam Dasari et al. EUROPEAN JOURNAL OF PHARMACOLOGY
- ABCG2 regulates the pattern of self-renewing divisions in cisplatin-resistant non-small cell lung cancer cell lines
- (2014) YING TANG et al. ONCOLOGY REPORTS
- The chemosensitivity of testicular germ cell tumors
- (2014) Ioannis A. Voutsadakis CELLULAR ONCOLOGY
- Cisplatin Hypersensitivity of Testicular Germ Cell Tumors Is Determined by High Constitutive Noxa Levels Mediated by Oct-4
- (2013) M. Gutekunst et al. CANCER RESEARCH
- Acquisition of epithelial–mesenchymal transition phenotype and cancer stem cell-like properties in cisplatin-resistant lung cancer cells through AKT/β-catenin/Snail signaling pathway
- (2013) Hao Wang et al. EUROPEAN JOURNAL OF PHARMACOLOGY
- PARP expression in germ cell tumours
- (2013) Michal Mego et al. JOURNAL OF CLINICAL PATHOLOGY
- Activity of aaptamine and two derivatives, demethyloxyaaptamine and isoaaptamine, in cisplatin-resistant germ cell cancer
- (2013) Sergey A. Dyshlovoy et al. Journal of Proteomics
- Salinomycin induces apoptosis in cisplatin-resistant colorectal cancer cells by accumulation of reactive oxygen species
- (2013) Jin Zhou et al. TOXICOLOGY LETTERS
- EMT transcription factors snail and slug directly contribute to cisplatin resistance in ovarian cancer
- (2012) Alexandria M Haslehurst et al. BMC CANCER
- Cytotoxic effect of disulfiram/copper on human glioblastoma cell lines and ALDH-positive cancer-stem-like cells
- (2012) P Liu et al. BRITISH JOURNAL OF CANCER
- Cisplatin resistance induced in germ cell tumour cells is due to reduced susceptibility towards cell death but not to altered DNA damage induction or repair
- (2012) Annabelle E. Fenske et al. CANCER LETTERS
- Cisplatin Selects for Multidrug-Resistant CD133+ Cells in Lung Adenocarcinoma by Activating Notch Signaling
- (2012) Y.-P. Liu et al. CANCER RESEARCH
- Progression-free and overall survival in patients with relapsed/refractory germ cell tumors treated with single-agent chemotherapy: Endpoints for clinical trial design
- (2011) Darren R. Feldman et al. CANCER
- Long-Term Survival After Treatment with Gemcitabine and Oxaliplatin With and Without Paclitaxel Plus Secondary Surgery in Patients with Cisplatin-Refractory and/or Multiply Relapsed Germ Cell Tumors
- (2011) Karin Oechsle et al. EUROPEAN UROLOGY
- Dissecting the molecular pathways of (testicular) germ cell tumour pathogenesis; from initiation to treatment-resistance
- (2011) L. H. J. Looijenga et al. INTERNATIONAL JOURNAL OF ANDROLOGY
- Micro-RNA expression in cisplatin resistant germ cell tumor cell lines
- (2011) Matthias Port et al. Molecular Cancer
- Molecular mechanisms of cisplatin resistance
- (2011) L Galluzzi et al. ONCOGENE
- Increased expression of urokinase plasminogen activator and its cognate receptor in human seminomas
- (2010) Salvatore Ulisse et al. BMC CANCER
- Histological evidence for the existence of germ cell tumor cells showing embryonal carcinoma morphology but lacking OCT4 expression and cisplatin sensitivity
- (2010) Thomas Mueller et al. HISTOCHEMISTRY AND CELL BIOLOGY
- Prognostic Factors in Patients With Metastatic Germ Cell Tumors Who Experienced Treatment Failure With Cisplatin-Based First-Line Chemotherapy
- (2010) JOURNAL OF CLINICAL ONCOLOGY
- Synthetic isothiocyanate indole-3-ethyl isothiocyanate (homoITC) enhances sensitivity of human ovarian carcinoma cell lines A2780 and A2780/CP to cisplatin
- (2010) P. Stehlik et al. NEOPLASMA
- The relative activity of cisplatin, oxaliplatin and satraplatin in testicular germ cell tumour sensitive and resistant cell lines
- (2009) Jackie Perry et al. CANCER CHEMOTHERAPY AND PHARMACOLOGY
- Cytosine deaminase expressing human mesenchymal stem cells mediated tumour regression in melanoma bearing mice
- (2008) Lucia Kucerova et al. JOURNAL OF GENE MEDICINE
- Increased expression and nuclear localization of the centrosomal kinase Nek2 in human testicular seminomas
- (2008) Federica Barbagallo et al. JOURNAL OF PATHOLOGY
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now